Park Jade O, Webb Carmen E, Temple-Oberle Claire F
Undergraduate Medical Education, University of Calgary, Calgary, Alberta, Canada.
Departments of Surgery and Oncology, University of Calgary, Calgary, Alberta, Canada.
Plast Reconstr Surg Glob Open. 2021 Oct 14;9(10):e3843. doi: 10.1097/GOX.0000000000003843. eCollection 2021 Oct.
Breast implant associated anaplastic large cell lymphoma (BIA-ALCL) is a T-cell non-Hodgkin's lymphoma and an uncommon risk of textured breast implants. Over the past decade, concern about BIA-ALCL has been increasing among both patients and surgeons. Patients are seeking a better understanding of their BIA-ALCL risk toward identifying a personalized care plan. This quality improvement project examines the value added by pairing group-based patient education seminars with one-on-one consults.
Individual consults were held following educational group seminars. Consult field notes underwent qualitative thematic analysis. Themes were cross referenced against a quantitative chart review of patient BIA-ALCL prophylaxis decisions over time.
Four key themes were identified: weighing, perceiving, guiding, and supporting. considers the risk-benefit assessments patients make when weighing their BIA-ALCL risk. describes the underlying psychosocial factors that frame patient perceptions of BIA-ALCL risk. presents the levels of guidance that patients require when making BIA-ALCL prophylaxis decisions. explores the therapeutic value of the individual consult. Ultimately, 41% of post-seminar consult attendees sought explantation, compared with 4% among patients who did not participate in this program ( < 0.001).
Key lessons include the following: (1) patients weigh BIA-ALCL risk against perceived surgical risks and the value of their reconstruction; (2) patients can benefit from a personalized balance of autonomy and surgeon guidance when selecting a BIA-ALCL prevention plan; (3) surgeons should seek to understand the psychosocial factors that may underlie patient perceptions of BIA-ALCL risk; and (4) individual consults can be therapeutic and help strengthen the patient-surgeon relationship.
乳房植入物相关间变性大细胞淋巴瘤(BIA-ALCL)是一种T细胞非霍奇金淋巴瘤,是有纹理乳房植入物的一种罕见风险。在过去十年中,患者和外科医生对BIA-ALCL的关注都在增加。患者希望更好地了解自己患BIA-ALCL的风险,以便制定个性化的护理计划。这个质量改进项目研究了将基于小组的患者教育研讨会与一对一咨询相结合所带来的价值。
在教育小组研讨会之后进行个人咨询。咨询现场记录进行了定性主题分析。将主题与患者BIA-ALCL预防决策随时间变化的定量图表回顾进行交叉参考。
确定了四个关键主题:权衡、认知、指导和支持。“权衡”考虑了患者在权衡其BIA-ALCL风险时所做的风险效益评估。“认知”描述了构成患者对BIA-ALCL风险认知的潜在社会心理因素。“指导”呈现了患者在做出BIA-ALCL预防决策时所需的指导水平。“支持”探讨了个人咨询的治疗价值。最终,参加研讨会后咨询的患者中有41%寻求取出植入物,而未参加该项目的患者中这一比例为4%(P<0.001)。
关键经验教训如下:(1)患者会将BIA-ALCL风险与感知到的手术风险以及重建的价值进行权衡;(2)患者在选择BIA-ALCL预防计划时,可以从自主性和外科医生指导的个性化平衡中受益;(3)外科医生应设法了解可能构成患者对BIA-ALCL风险认知基础的社会心理因素;(4)个人咨询具有治疗作用,有助于加强患者与外科医生的关系。